Back
Cardinal Health Vs. Kymera Therapeutics Industry Stock Comparison
Sell
34
CAH
Cardinal Health
Last Price:
108.49
Seasonality Move:
9.69%
Buy
62
KYMR
Kymera Therapeutics
Last Price:
46.17
Seasonality Move:
69.6%
Sell
34
Cardinal Health (CAH)
is a Sell
Is Cardinal Health a Buy, Sell or Hold?
- The current Cardinal Health [CAH] share price is $107.89. The Score for CAH is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- CAH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $47.65. The Score for KYMR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CAH Stock Price Chart
What is Cardinal Health's stock price today?
-
The Cardinal Health share price today is $107.89
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CAH is experiencing slight selling pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $47.65
The current trend is moderately bearish and KYMR is experiencing slight selling pressure.
CAH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.21 | Sell |
Relative Strength Index (14 RSI): | 32.83 | Sell |
Chaikin Money Flow: | -790772 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (109.84 - 112.86) | Sell |
Bollinger Bands (100): | (98.85 - 112.23) | Buy |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.6 | Buy |
Relative Strength Index (14 RSI): | 52.44 | Buy |
Chaikin Money Flow: | -88534 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.05 - 49.09) | Buy |
Bollinger Bands (100): | (36.61 - 48.91) | Buy |
CAH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 111.04 | Sell |
20-day SMA: | 111.75 | Sell |
50-day SMA: | 111.53 | Sell |
200-day SMA: | 105.48 | Buy |
8-day EMA: | 110.56 | Sell |
20-day EMA: | 111.23 | Sell |
50-day EMA: | 110.02 | Sell |
200-day EMA: | 104.46 | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.2 | Sell |
20-day SMA: | 46.01 | Buy |
50-day SMA: | 47.06 | Buy |
200-day SMA: | 39.57 | Buy |
8-day EMA: | 47.93 | Sell |
20-day EMA: | 47.19 | Buy |
50-day EMA: | 46.06 | Buy |
200-day EMA: | 39.32 | Buy |
Cardinal Health Earnings Growth & CAH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.62 per share, and an increase next year of $0.27 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.
Cardinal Health Technical Analysis
Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |